Pediatric Patients with Cardiomyopathy due to MYBPC3 Mutations
Pediatric patients with Cardiomyopathy due to MYBPC3 Mutations are asked to participate in a research study being conducted by the Icahn School of Medicine at Mount Sinai.
You may be eligible to participate in this study if you:
• Are 18 years old
• Have at least one MYBPC3 mutation
You may not participate in this study if you:
• Are currently participating in an interventional clinical trial
• Have a severe noncardiac disease
Contact Information
Erin Carlin, Study Coordinator
Phone: (212)-659-8980
Email: ERIN.CARLIN@MSSM.EDU
21-10-323